Acceptability and side effects of Cyclofem© once-a-month injectable contraceptive in Kerman, Iran

  • سال انتشار: 1389
  • محل انتشار: International Journal of Reproductive BioMedicine، دوره: 8، شماره: 4
  • کد COI اختصاصی: JR_IJRM-8-4_009
  • زبان مقاله: انگلیسی
  • تعداد مشاهده: 574
دانلود فایل این مقاله

نویسندگان

Mahdieh Yazdanpanah

Kerman Neuroscience Research Center, Kerman University of Medical Sciences, Kerman, Iran.

Mohammad Eslami

Family Planning Bureau, Ministry of Health, Tehran, Iran.

Parnian Andalib

Family Planning Bureau, Ministry of Health, Tehran, Iran.

Mohammad Esmaaeil Motlaq

Department of Paediatrics, Ahwaz University of Medical Sciences, Ahwaz, Iran.

چکیده

Background: When family planning programmes offer a wide variety of contraceptives, contraceptive prevalence would be higher overall.Objective: To determine the acceptability of Cyclofem© and to evaluate its side effects and continuation rate in Iran.Materials and Methods: An introductory study of Cyclofem© was conducted in seven districts of Kerman Province, the largest province of Iran, in three phases. At first, 14394 women attending randomly selected urban and rural health centers representing different socioeconomic classes were invited to choose Cyclofem© after a standard schedule of counselling. At the second phase 418 of those who accepted Cyclofem© and 354 of those who refused to use the method were randomly selected to participate in an interview. At the third phase the first group was followed up for one year at regular one-month intervals.Results: Nearly 12.6% (n=1809) of 14394 women counselled to choose Cyclofem© accepted the contraceptive method. They had a mean (±SD) age of 28.5 (±6.5) years. Fear of side effects was the most common cause of refusal to use Cyclofem©. The one-year continuation rate was 21.2%. The three main side effects leading to early discontinuation of Cyclofem© were nausea (18%), prolonged menses (15.8%), and amenorrhea (14.7%), respectively.Conclusion: The one-year continuation rate of Cyclofem© use in Iran has been lower than other countries. Further research is necessary to improve continuation rates.

کلیدواژه ها

Injectable contraceptives, Side effects, Family planning, Cyclofem©, Iran

اطلاعات بیشتر در مورد COI

COI مخفف عبارت CIVILICA Object Identifier به معنی شناسه سیویلیکا برای اسناد است. COI کدی است که مطابق محل انتشار، به مقالات کنفرانسها و ژورنالهای داخل کشور به هنگام نمایه سازی بر روی پایگاه استنادی سیویلیکا اختصاص می یابد.

کد COI به مفهوم کد ملی اسناد نمایه شده در سیویلیکا است و کدی یکتا و ثابت است و به همین دلیل همواره قابلیت استناد و پیگیری دارد.